PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
28-Feb-2020 AXON Gets Another Wellbeing Award Nod from Great Place to Work® UK AXON
28-Feb-2020 iOnctura announces first patient dosed in a phase I clinical study of its novel highly selective PI3Kδ inhibitor, IOA-244 for solid tumours iOnctura
28-Feb-2020 NEW RESEARCH REVEALS THE NEED FOR GREATER UNDERSTANDING OF EUROPEAN PHARMACEUTICAL MARKETS TO MAXIMISE DIGITAL STRATEGIES Bryter
28-Feb-2020 MR Solutions’ dry magnet MRI system for molecular imaging on display at EMIM 2020 MR Solutions’
28-Feb-2020 Kiadis Pharma announces FDA clearance of clinical study by The Ohio State University in R/R AML with off-the-shelf NK cells from universal donors Kiadis
28-Feb-2020 Coronavirus (COVID-19) Supply Chain Update U.S. Food and Drug Administration
27-Feb-2020 BERG Files Patent Application For First In Class Small Molecule Modulators Of A Novel Target Identified By BERG's Interrogative Biology® Platform BERG Health
27-Feb-2020 Mallinckrodt to Present New Data from two Studies on Acthar® Gel (Repository Corticotropin Injection) Therapy in Multiple Sclerosis (MS) Relapse at Fifth Annual ACTRIMS Forum 2020 Mallinckrodt Pharmaceuticals
27-Feb-2020 Mallinckrodt to Present New Data from two Studies on Acthar® Gel (Repository Corticotropin Injection) Therapy in Multiple Sclerosis (MS) Relapse at Fifth Annual ACTRIMS Forum 2020 Mallinckrodt Pharmaceuticals
27-Feb-2020 Nordic Nanovector ASA - resultat for fjerde kvartal og helår 2019 Nordic Nanovector
27-Feb-2020 Nordic Nanovector ASA - resultat for fjerde kvartal og helar 2019 Nordic Nanovector
26-Feb-2020 Natera Reports Fourth Quarter and Year 2019 Financial Results Natera, Inc.
26-Feb-2020 REGENXBIO Reports Fourth Quarter and Full-Year 2019 Financial Results and Operational Highlights REGENXBIO Inc.
26-Feb-2020 Oramed Pharmaceuticals Inc. Announces Proposed Public Offering of Common Stock Oramed Pharmaceuticals Inc.
26-Feb-2020 Active Motif clones, sequences and expresses the first full human antibody derived from patients infected with the 2019 Coronavirus COVID-19 Active Motif
26-Feb-2020 BioMarin Announces Fourth Quarter and Record Full-year 2019 Financial Results BioMarin Pharmaceutical Inc.
26-Feb-2020 Halozyme Therapeutics To Present At The Cowen 40th Annual Health Care Conference Halozyme Therapeutics, Inc.
26-Feb-2020 GenomSys relocates its headquarters to Biopôle, Lausanne GenomSys
26-Feb-2020 Dialectic Therapeutics Receives $3 Million Seed Award for Product Development Research from the Cancer Prevention & Research Institute of Texas Dialectic Therapeutics, Inc.
26-Feb-2020 Scientists Announce VIRGO, First Comprehensive Gene Catalog To Decode the Vaginal Microbiome LUCA Biologics